Compare iShares China Large-Cap ETF (FXI) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares China Large-Cap ETF vs Nomura Holdings Inc — how do they compare? iShares China Large-Cap ETF trades at $34.25 (market cap $3.86B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: Nomura Holdings Inc is far larger — about 7.1× iShares China Large-Cap ETF's market cap, and Nomura Holdings Inc pays a 3.4% dividend while iShares China Large-Cap ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 150 Days and Nomura Holdings Inc for 55 Days on average.
| FXI | NMR | |
|---|---|---|
Market Cap | $3.86B | $27.55B |
Volume | 16,323,837 | 782,470 |
52-Week High | $41.08 | $10.86 |
52-Week Low | $31.59 | $6.73 |
Typical Hold Time | 150 Days | 55 Days |
Sector | — | Financials |
Enterprise Value | — | $38.54T |
Dividend Yield | — | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FXI trades at $33.45 with minimal daily movement (+0.09%), reflecting subdued momentum amid bearish technical signals. The ETF faces significant technical headwinds with 17 sell signals versus 1 buy, though oscillators remain neutral. Recent news highlights China's mixed economic signals, including strong export growth but persistent overcapacity concerns. The Trump-Xi summit in September 2026 offered limited progress on trade tensions, maintaining geopolitical uncertainty for Chinese equities.
FXI presents a value opportunity with a P/E ratio of 11.10—half the S&P 500's valuation—and a 1.98% yield, but faces substantial risks from China's economic rebalancing, weak domestic consumption, and potential export controls. Investor sentiment is cautious due to political and macroeconomic headwinds, though some analysts see long-term potential if China stabilizes growth.
Nomura Holdings (NMR) trades at $9.54, up 0.1% today, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Revenue grew to $1.66 trillion in 2025, and the stock has recently been added to Zacks Strong Buy lists, indicating positive momentum recognition. Cash flow trends show variability, with 2025 net cash flow positive at $126.42 billion despite negative operating cash flow.
The outlook is mixed; solid profitability and low valuation ratios support upside potential, but recent earnings misses and a bearish technical backdrop pose near-term risks. Analyst consensus leans hold (66.67%), suggesting cautious optimism. Key risks include debt level increases and macroeconomic sensitivity affecting Japan's bond market, as noted by Nomura's own analysis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
